Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK251

Copy Product Info
😃Good
Catalog No. T39573Cas No. 2125968-05-8

GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.

GSK251

GSK251

Copy Product Info
😃Good
Purity: 99.8%
Catalog No. T39573Cas No. 2125968-05-8
GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$166-In Stock
5 mg$417-In Stock
10 mg$592-In Stock
25 mg$882-In Stock
50 mg$1,180-In Stock
100 mg$1,600-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.8%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

GSK251 AI Summary
GSK251 shows potent inhibitory activity against the PI3K isoforms PI3Kalpha, PI3Kbeta, PI3Kdelta, and PI3Kgamma PH domains, with an IC50 value of <= 10000.0 nM when tested using a TR-FRET assay. Notably, it exhibits high affinity and selectivity for PI3Kdelta, demonstrating low nanomolar IC50 and Ki values of 0.7943 nM and 0.01259 nM, respectively. The compound also has good oral bioavailability (46.0%) and moderate clearance in rats, with a half-life of 2.6 hours, indicating its potential as an effective PI3K inhibitor with promising pharmacokinetic properties..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode.
Chemical Properties
Molecular Weight584.71
FormulaC29H37FN6O4S
Cas No.2125968-05-8
SmilesCOc1ncc(cc1S(=O)(=O)Nc1ccnc(c1)-c1ccc(CN2CCN(CC2)C(C)C)cc1F)N1CCOCC1
Relative Density.1.295 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (85.51 mM), Sonication and heating to 60℃ are recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.42 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7102 mL8.5512 mL17.1025 mL85.5125 mL
5 mM0.3420 mL1.7102 mL3.4205 mL17.1025 mL
10 mM0.1710 mL0.8551 mL1.7102 mL8.5512 mL
20 mM0.0855 mL0.4276 mL0.8551 mL4.2756 mL
50 mM0.0342 mL0.1710 mL0.3420 mL1.7102 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK251 | purchase GSK251 | GSK251 cost | order GSK251 | GSK251 chemical structure | GSK251 formula | GSK251 molecular weight